BR0211422A - Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto - Google Patents

Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto

Info

Publication number
BR0211422A
BR0211422A BR0211422-4A BR0211422A BR0211422A BR 0211422 A BR0211422 A BR 0211422A BR 0211422 A BR0211422 A BR 0211422A BR 0211422 A BR0211422 A BR 0211422A
Authority
BR
Brazil
Prior art keywords
compound
formula
ester
salt
preparation
Prior art date
Application number
BR0211422-4A
Other languages
English (en)
Inventor
Pau Cid
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8183486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0211422(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Publication of BR0211422A publication Critical patent/BR0211422A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE UM COMPOSTO OU DE UM éSTER OU UM SAL DO MESMO, E, COMPOSTO". Processo para a preparação de um composto da fórmula (IV): ou um éster ou um sal do mesmo compreendendo 1) a reação de um composto da fórmula (I): (onde R~ a~ representa C~ 1-4~alquila, R~ b~ representa C~ 1-4~ alquila e R~ c~ representa C~ 1-6~ alquila) com composto da fórmula X~ 2~C=O (onde cada X representa independentemente um grupo que sai) para produzir um composto da fórmula (II): (onde R~ a~, R~ b~ e R~ c~ são como definidos aqui anteriormente); e 2) a reação do referido composto da fórmula (II) com um composto da fórmula (III): (onde R~ d~ representa hidrogênio ou um grupo protetor).
BR0211422-4A 2001-07-24 2002-07-23 Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto BR0211422A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01500197 2001-07-24
PCT/EP2002/008223 WO2003010142A2 (en) 2001-07-24 2002-07-23 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds

Publications (1)

Publication Number Publication Date
BR0211422A true BR0211422A (pt) 2004-08-17

Family

ID=8183486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211422-4A BR0211422A (pt) 2001-07-24 2002-07-23 Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto

Country Status (24)

Country Link
US (1) US20040248814A1 (pt)
EP (1) EP1279665B1 (pt)
JP (1) JP4083118B2 (pt)
KR (1) KR100694528B1 (pt)
CN (1) CN100503568C (pt)
AR (1) AR036187A1 (pt)
AT (1) ATE386717T1 (pt)
AU (1) AU2002328954B2 (pt)
BR (1) BR0211422A (pt)
CY (1) CY1107403T1 (pt)
DE (1) DE60225092T2 (pt)
DK (1) DK1279665T3 (pt)
EA (1) EA007000B1 (pt)
ES (1) ES2300402T3 (pt)
HK (1) HK1067129A1 (pt)
HU (1) HUP0202414A3 (pt)
MX (1) MXPA04000649A (pt)
NO (1) NO20040278L (pt)
NZ (1) NZ530578A (pt)
PL (1) PL355161A1 (pt)
PT (1) PT1279665E (pt)
SI (1) SI1279665T1 (pt)
WO (1) WO2003010142A2 (pt)
ZA (1) ZA200400323B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289060T3 (es) 2002-01-30 2008-02-01 Les Laboratoires Servier Proceso para la preparacion de perindopril de alta pureza y de intermedios utiles en su sintesis.
ES2307923T3 (es) 2003-02-28 2008-12-01 Les Laboratoires Servier S.A. Procedimiento de preparacion de perindopril y sales del mismo.
ES2386161T3 (es) 2003-04-16 2012-08-10 Bristol-Myers Squibb Company Proceso para separar una mezcla de enantiómeros de éster alquílico usando una enzima
SI21506A (sl) * 2003-05-08 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo perindoprila
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
AU2003263584A1 (en) * 2003-08-21 2005-03-10 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
AU2003300689B2 (en) * 2003-10-21 2009-01-29 Les Laboratoires Servier Novel method for preparation of crystalline perindopril erbumine
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
US7960558B2 (en) 2006-05-12 2011-06-14 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
EP2150538B1 (en) 2007-06-06 2012-03-28 DSM Sinochem Pharmaceuticals Netherlands B.V. Novel 5-substituted hydantoins
FR2985512B1 (fr) 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
LU88621I2 (fr) * 1980-10-23 1995-09-01 Schering Corp Sandopril
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
US4558038A (en) 1981-03-30 1985-12-10 Usv Pharmaceutical Corp. N-Substituted-amindo-amino acids
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
JPS6248696A (ja) 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd Ｎ−〔１（ｓ）−エトキシカルボニル−３−フエニルプロピル〕−ｌ−アラニル−ｌ−プロリンの製造法
ES2004804A6 (es) * 1987-08-13 1989-02-01 Pharma Investi S A Un procedimiento para preparar derivados de carboxialquildipeptidos
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
US5258525A (en) * 1991-03-27 1993-11-02 Mcneilab, Inc. Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters
SI9200213A (en) * 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
IN184759B (pt) 1997-07-22 2000-09-23 Kaneka Corp
SE0000382D0 (sv) * 2000-02-07 2000-02-07 Astrazeneca Ab New process

Also Published As

Publication number Publication date
JP4083118B2 (ja) 2008-04-30
HK1067129A1 (en) 2005-04-01
NO20040278L (no) 2004-01-21
WO2003010142A2 (en) 2003-02-06
AR036187A1 (es) 2004-08-18
NZ530578A (en) 2007-02-23
ATE386717T1 (de) 2008-03-15
EP1279665B1 (en) 2008-02-20
ZA200400323B (en) 2005-03-30
JP2005501829A (ja) 2005-01-20
KR100694528B1 (ko) 2007-03-13
AU2002328954B2 (en) 2007-10-04
DE60225092T2 (de) 2009-02-19
KR20040029378A (ko) 2004-04-06
DK1279665T3 (da) 2008-06-23
CN100503568C (zh) 2009-06-24
CN1529694A (zh) 2004-09-15
US20040248814A1 (en) 2004-12-09
HU0202414D0 (pt) 2002-09-28
HUP0202414A3 (en) 2003-05-28
PT1279665E (pt) 2008-03-28
PL355161A1 (en) 2003-01-13
CY1107403T1 (el) 2012-12-19
WO2003010142A3 (en) 2003-08-28
EP1279665A3 (en) 2003-03-12
EP1279665A2 (en) 2003-01-29
SI1279665T1 (sl) 2008-06-30
MXPA04000649A (es) 2004-10-27
DE60225092D1 (de) 2008-04-03
ES2300402T3 (es) 2008-06-16
EA007000B1 (ru) 2006-06-30
EA200400129A1 (ru) 2004-08-26
HUP0202414A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
BR0211422A (pt) Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
MX171822B (es) Proceso quimico
CA2305313A1 (en) Acylsulfamoylbenzamides, crop protection compositions comprising them, and processes for their preparation
BR0114252A (pt) Derivados de nitrosodifenilamina
BR0113180A (pt) Composto de acilacetonitrila, processo para sua preparação e miticida contendo o mesmo
PT1038875E (pt) Derivados de imidazopiridina e processo para os preparar
CA2354774A1 (en) Farnesyl protein transferase inhibitors
DE69921151D1 (de) Fluorszierende marker
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR0211291A (pt) Derivados de diamina, processo para produção dos derivados de diamina e fungicidas contendo os derivados de diamina como ingrediente ativo
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0115996A (pt) Sulfamidotienopirimidinas
ATE405671T1 (de) Zusammensetzungen zur verbesserung der card(catalyzed reporter deposition)-technik
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR9900544A (pt) Processos para a preparação de um composto de 2-aril-5- (perfluoro-alquil)-pirrol e de um composto de aril-pirrol, e composto de cloreto de n-(perfluoro-alquil-metil)-aril-imidoìla.
BR9813733A (pt) Processo para produção de um composto
BR0009453A (pt) Processo para a preparação de um composto
AR051991A1 (es) Procedimiento para la preparacion de anilinas
BR0004787A (pt) Processo para a preparação de compostos pirazolo[4,3-d] pirimidin-7-onas-3-piridilsulfonila bem como intermediários dos mesmos
BR0210894A (pt) Derivados de benzo(g) quinolina
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
BR0113170A (pt) Processo para a preparação de dinapsolina
BR9909151A (pt) processos para preparação de intermediários

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2162 DE 12/06/2012.